Budesonide treatment of patients with co
β
Michael Wagner; Maria Lampinen; Per Sangfelt; Margret Agnarsdottir; Marie Carlso
π
Article
π
2010
π
John Wiley and Sons
π
English
β 495 KB
## Background: The aim of this study was to assess the activity of eosinophils, neutrophils, and CD4ΓΎ as well as CD8ΓΎ T-cells in 11 patients with active collagenous colitis (CC) before and after 8 weeks of budesonide treatment (9 mg once daily) compared to 10 healthy individuals. Methods: Clinica